Novak Djokovic owns a majority stake in a Danish biotech company that aims to develop a medical treatment to fight the coronavirus, the company’s chief executive has said.
QuantBioRes CEO Ivan Loncarevic disclosed the news to Reuters on Wednesday, explaining that the Serbian star owns an 80% stake.
Loncarevic said the tennis world number one – who has amassed more than $150 million in career prize money – made the investment in June 2020, but did not disclose the amount.
No hay comentarios:
Publicar un comentario